Griesshammer M - Search Results

1

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis.

Klippel S, Strunck E, Temerinac S, Bench AJ, Meinhardt G, Mohr U, Leichtle R, Green AR, Griesshammer M, Heimpel H, Pahl HL. Klippel S, et al. Among authors: griesshammer m. Blood. 2003 Nov 15;102(10):3569-74. doi: 10.1182/blood-2003-03-0919. Epub 2003 Jul 31. Blood. 2003. PMID: 12893745 Free article.

2

[Chronic myeloid leukemia--latest aspects and practical progress in recent years].

Griesshammer M, Heimpel H. Griesshammer M, et al. Med Klin (Munich). 1995 Sep 15;90(9):527-31. Med Klin (Munich). 1995. PMID: 7476731 Review. German. No abstract available.

3

Essential thrombocythemia and pregnancy.

Griesshammer M, Heimpel H, Pearson TC. Griesshammer M, et al. Leuk Lymphoma. 1996 Sep;22 Suppl 1:57-63. doi: 10.3109/10428199609074361. Leuk Lymphoma. 1996. PMID: 8951773 Review.

4

Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients.

Griesshammer M, Heinze B, Hellmann A, Popp C, Anger B, Heil G, Bangerter M, Heimpel H. Griesshammer M, et al. Ann Hematol. 1996 Nov;73(5):225-30. doi: 10.1007/s002770050233. Ann Hematol. 1996. PMID: 8959940

5

The abundant presence of Söderström bodies in cytology smears of fine-needle aspirates contributes to distinguishing high-grade non-Hodgkin's lymphoma from carcinoma and sarcoma.

Bangerter M, Herrmann F, Griesshammer M, Gruss HJ, Hafner M, Heimpel H, Binder T. Bangerter M, et al. Among authors: griesshammer m. Ann Hematol. 1997 Apr;74(4):175-8. doi: 10.1007/s002770050278. Ann Hematol. 1997. PMID: 9174545

6

Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia.

Griesshammer M, Heinze B, Bangerter M, Heimpel H, Fliedner TM. Griesshammer M, et al. J Mol Med (Berl). 1997 Nov-Dec;75(11-12):836-8. doi: 10.1007/s001090050173. J Mol Med (Berl). 1997. PMID: 9428614

7

Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemia.

Griesshammer M, Kubanek B, Beneke H, Heimpel H, Bangerter M, Bergmann L, Schrezenmeier H. Griesshammer M, et al. Leuk Lymphoma. 2000 Feb;36(5-6):533-8. doi: 10.3109/10428190009148401. Leuk Lymphoma. 2000. PMID: 10784398

8

PRV-1 mRNA expression discriminates two types of essential thrombocythemia.

Griesshammer M, Klippel S, Strunck E, Temerinac S, Mohr U, Heimpel H, Pahl HL. Griesshammer M, et al. Ann Hematol. 2004 Jun;83(6):364-70. doi: 10.1007/s00277-004-0864-9. Epub 2004 Mar 18. Ann Hematol. 2004. PMID: 15034760 Clinical Trial.

9

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.

Goerttler PS, Steimle C, März E, Johansson PL, Andreasson B, Griesshammer M, Gisslinger H, Heimpel H, Pahl HL. Goerttler PS, et al. Among authors: griesshammer m. Blood. 2005 Oct 15;106(8):2862-4. doi: 10.1182/blood-2005-04-1515. Epub 2005 Jun 28. Blood. 2005. PMID: 15985544 Free article.

10

Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.

Langer C, Lengfelder E, Thiele J, Kvasnicka HM, Pahl HL, Beneke H, Schauer S, Gisslinger H, Griesshammer M. Langer C, et al. Among authors: griesshammer m. Haematologica. 2005 Oct;90(10):1333-8. Haematologica. 2005. PMID: 16219569 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters